The combination of a death receptor 5 agonist antibody and Salinomycin is a potent anti-aging drug cocktail and the combination triggers immune destruction of senescent cancer cells mediated by natural killer cells and CD 8 + T cells with the involvement of interleukin-18. The gene discussed is TNFRSF10B; the disease is cancer.